Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jillian Raybould"'
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3, Pp s87-s87 (2023)
Background: Academic publishing is not exempt from potential structural disparities. We assessed the sex representation among the editors and on editorial boards by their level of influence in the decision of a manuscript of the leading journals focu
Externí odkaz:
https://doaj.org/article/1b2b6c55e7a245c58a2b7ca9d6f5cdb2
Autor:
Aldo Barajas-Ochoa, Manuel Ramirez-Trejo, Paloma Gradilla-Magaña, Aditee Dash, Jillian Raybould, Gonzalo Bearman
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Diversity is recognized as a driver of excellence and innovation. Women represent a significant part of the infectious diseases (ID) and hospital epidemiology (HE) workforce. We aimed to assess gender representation among editors
Externí odkaz:
https://doaj.org/article/628980cafcf74203a4773a3afa593973
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 9, Pp 2459-2461 (2021)
A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis. This emerging pathogen has been increasingly identified as a clinically significant pathogen in imm
Externí odkaz:
https://doaj.org/article/85c2e975daec4fd082aab4097d929338
Autor:
Ahmed Ullah Mishuk, Jeffrey R Strich, Sarah Warner, Junfeng Sun, Seidu Malik, Alexander Lawandi, Maiko Kondo, Michael J Satlin, Aditya Chandorkar, Emily L Heil, Megan K Morales, Anisha Mathur, Joseph Timpone, Darcy Wooten, Daniel Sweeney, Jonathan Pan, Jillian Raybould, Stephanie Bonne, Roberto Colindres, Helen W Boucher, Sara Buckman, Daisuke Furukawa, Daniel Uslan, Samuel F Hohmann, Sameer S Kadri
Publikováno v:
Open Forum Infectious Diseases. 9
Background Ceftazidime-avibactam (caz-avi), a novel β-lactam/β-lactamase inhibitor, is commonly utilized for carbapenem-resistant gram-negative infections (CR-GNI). However, the benefits vs risks of combining caz-avi with other agents are unclear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::578c0ccefc14f360cca2d2c18a30342e
https://doi.org/10.1093/ofid/ofac492.704
https://doi.org/10.1093/ofid/ofac492.704